| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: PRAI |
| Security Type |
Common Stock |
| Lead Underwriter |
Credit Suisse First Boston Bear Stearns & Co Inc |
| Days In Registration |
20 |
| Date Filed |
28-Oct-2004 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Pers/Bus/Rep Svc |
| Business Description |
Provide clinical drug research and development services on a worldwide basis primarily to the pharmaceutical and biotechnology industries |
| Revenue |
$307.6M |
| Net Income |
$20.7M |
| Shares Outstanding (post-offering) |
22.12M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
6.0M |
| Secondary Shares Filed | 2.4M |
| · As a Percent |
40.0 |
| Primary Shares Filed |
3.6M |
| · As a Percent |
60.0 |
| Overallotment Shares Filed |
900.0K |
| File Amount |
$102.0M |
| File Price Range |
$18.00 - $16.00 |
| File Mid Price |
$17.00 |
Current Filing Information
(Amended 16-Nov-2004) |
|
US |
|
Shares Filed |
6.0M |
| Secondary Shares Filed |
2.4M |
| · As a Percent |
40.0 |
| Primary Shares Filed |
3.6M |
| · As a Percent |
60.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$102.0M |
| · % Change from Original |
0.0 |
| File Price Range |
$18.00 - $16.00 |
| File Mid Price |
$17.00 |
|
